Subjects -> MEDICAL SCIENCES (Total: 8529 journals)
    - ALLERGOLOGY AND IMMUNOLOGY (216 journals)
    - ANAESTHESIOLOGY (120 journals)
    - CARDIOVASCULAR DISEASES (332 journals)
    - CHIROPRACTIC, HOMEOPATHY, OSTEOPATHY (21 journals)
    - COMMUNICABLE DISEASES, EPIDEMIOLOGY (231 journals)
    - DENTISTRY (292 journals)
    - DERMATOLOGY AND VENEREOLOGY (164 journals)
    - EMERGENCY AND INTENSIVE CRITICAL CARE (120 journals)
    - ENDOCRINOLOGY (150 journals)
    - FORENSIC SCIENCES (41 journals)
    - GASTROENTEROLOGY AND HEPATOLOGY (186 journals)
    - GERONTOLOGY AND GERIATRICS (136 journals)
    - HEMATOLOGY (155 journals)
    - HYPNOSIS (4 journals)
    - INTERNAL MEDICINE (167 journals)
    - LABORATORY AND EXPERIMENTAL MEDICINE (99 journals)
    - MEDICAL GENETICS (58 journals)
    - MEDICAL SCIENCES (2342 journals)
    - NURSES AND NURSING (362 journals)
    - OBSTETRICS AND GYNECOLOGY (207 journals)
    - ONCOLOGY (381 journals)
    - OPHTHALMOLOGY AND OPTOMETRY (138 journals)
    - ORTHOPEDICS AND TRAUMATOLOGY (167 journals)
    - OTORHINOLARYNGOLOGY (82 journals)
    - PATHOLOGY (98 journals)
    - PEDIATRICS (273 journals)
    - PHYSICAL MEDICINE AND REHABILITATION (157 journals)
    - PSYCHIATRY AND NEUROLOGY (822 journals)
    - RADIOLOGY AND NUCLEAR MEDICINE (192 journals)
    - RESPIRATORY DISEASES (103 journals)
    - RHEUMATOLOGY (78 journals)
    - SPORTS MEDICINE (81 journals)
    - SURGERY (401 journals)
    - UROLOGY, NEPHROLOGY AND ANDROLOGY (153 journals)

DERMATOLOGY AND VENEREOLOGY (164 journals)                     

Showing 1 - 164 of 164 Journals sorted alphabetically
Acta Dermato-Venereologica     Open Access   (Followers: 12)
Acta Dermatovenerologica Croatica     Open Access   (Followers: 1)
Actas Dermo-Sifiliograficas     Full-text available via subscription   (Followers: 3)
Actas Dermo-Sifiliográficas (English Edition)     Full-text available via subscription   (Followers: 2)
Advances in Dermatology     Full-text available via subscription   (Followers: 16)
Advances in Skin & Wound Care     Hybrid Journal   (Followers: 31)
African Journal of AIDS Research     Hybrid Journal   (Followers: 8)
AIDS     Hybrid Journal   (Followers: 23)
AIDS Care: Psychological and Socio-medical Aspects of AIDS/HIV     Hybrid Journal   (Followers: 9)
AIDS Patient Care and STDs     Hybrid Journal   (Followers: 3)
AIDS Research and Human Retroviruses     Hybrid Journal   (Followers: 9)
AIDS Research and Therapy     Open Access   (Followers: 15)
AIDS Research and Treatment     Open Access   (Followers: 2)
Aktuelle Dermatologie     Hybrid Journal   (Followers: 7)
Allergo Journal     Full-text available via subscription   (Followers: 2)
American Journal of Clinical Dermatology     Full-text available via subscription   (Followers: 26)
American Journal of Dermatopathology     Hybrid Journal   (Followers: 17)
Anais Brasileiros de Dermatologia     Open Access   (Followers: 2)
Anaplastology     Open Access  
Annales de Dermatologie et de Vénéréologie     Full-text available via subscription  
Archives de Pédiatrie     Full-text available via subscription  
Archives de sciences sociales des religions     Open Access   (Followers: 1)
Archives des Maladies du Coeur et des Vaisseaux - Pratique     Hybrid Journal  
Archives of Dermatological Research     Hybrid Journal   (Followers: 7)
Archives of Gerontology and Geriatrics     Hybrid Journal   (Followers: 13)
Archives of Industrial Hygiene and Toxicology     Open Access   (Followers: 8)
Archives of Medical Research     Hybrid Journal   (Followers: 3)
Archives of Physical Medicine and Rehabilitation     Hybrid Journal   (Followers: 55)
Archivio di Ortopedia e Reumatologia     Hybrid Journal  
Asian Journal of Dermatology     Open Access   (Followers: 2)
ästhetische dermatologie & kosmetologie     Full-text available via subscription  
Australasian Journal of Dermatology     Hybrid Journal   (Followers: 8)
Berkala Ilmu Kesehatan Kulit dan Kelamin / Periodical of Dermatology and Venereology     Open Access  
Biomedical Dermatology     Open Access  
BMC Dermatology     Open Access   (Followers: 13)
BMJ Sexual & Reproductive Health     Hybrid Journal   (Followers: 2)
British Journal of Dermatology     Hybrid Journal   (Followers: 54)
Case Reports in Dermatological Medicine     Open Access   (Followers: 2)
Case Reports in Dermatology     Open Access   (Followers: 10)
Clinical and Experimental Dermatology     Hybrid Journal   (Followers: 14)
Clinical Dermatology Review     Open Access   (Followers: 5)
Clinical Skin Cancer     Full-text available via subscription  
Clinical, Cosmetic and Investigational Dermatology     Open Access   (Followers: 10)
Clinics in Dermatology     Hybrid Journal   (Followers: 15)
Contact Dermatitis     Hybrid Journal   (Followers: 8)
Cosmetics     Open Access   (Followers: 5)
Current Dermatology Reports     Hybrid Journal   (Followers: 7)
Current Fungal Infection Reports     Hybrid Journal   (Followers: 5)
Current HIV Research     Hybrid Journal   (Followers: 7)
Current HIV/AIDS Reports     Hybrid Journal   (Followers: 6)
Current Sexual Health Reports     Hybrid Journal   (Followers: 3)
Cutaneous and Ocular Toxicology     Hybrid Journal   (Followers: 10)
Der Hautarzt     Hybrid Journal   (Followers: 2)
Dermatitis     Hybrid Journal   (Followers: 1)
Dermato-Endocrinology     Open Access   (Followers: 2)
Dermatología Venezolana     Open Access  
Dermatologic Clinics     Full-text available via subscription   (Followers: 4)
Dermatologic Reviews     Hybrid Journal  
Dermatologic Surgery     Hybrid Journal   (Followers: 8)
Dermatologic Therapy     Hybrid Journal   (Followers: 2)
Dermatologica Sinica     Open Access  
Dermatological Nursing     Full-text available via subscription   (Followers: 2)
Dermatology     Full-text available via subscription   (Followers: 20)
Dermatology and Cosmetic     Open Access   (Followers: 8)
Dermatology and Therapy     Open Access   (Followers: 4)
Dermatology Online Journal     Open Access   (Followers: 1)
Dermatology Reports     Open Access   (Followers: 3)
Dermatology Research and Practice     Open Access   (Followers: 4)
Dermatology Times     Free  
Dermatopathology     Open Access   (Followers: 3)
Egyptian Journal of Dermatology and Venerology     Open Access   (Followers: 1)
EMC - Cosmetologia Medica e Medicina degli Inestetismi Cutanei     Full-text available via subscription  
EMC - Dermatología     Full-text available via subscription   (Followers: 1)
European Journal of Dermatology     Hybrid Journal   (Followers: 15)
Experimental Dermatology     Hybrid Journal   (Followers: 10)
Expert Review of Dermatology     Hybrid Journal   (Followers: 14)
Forum Dermatologicum     Hybrid Journal  
Graefe's Archive for Clinical and Experimental Ophthalmology     Hybrid Journal   (Followers: 8)
Güncel Dermatoloji Dergisi     Open Access  
HautinForm     Full-text available via subscription  
hautnah     Hybrid Journal  
hautnah dermatologie     Hybrid Journal  
HIV & AIDS Review     Full-text available via subscription   (Followers: 13)
HIV Clinical Trials     Hybrid Journal   (Followers: 5)
HIV Medicine     Hybrid Journal   (Followers: 3)
Indian Dermatology Online Journal     Open Access   (Followers: 3)
Indian Journal of Dermatology     Open Access   (Followers: 2)
Indian Journal of Dermatology, Venereology and Leprology     Open Access   (Followers: 4)
Indian Journal of Dermatopathology and Diagnostic Dermatology     Open Access  
Indian Journal of Drugs in Dermatology     Open Access   (Followers: 1)
Indian Journal of Paediatric Dermatology     Open Access   (Followers: 2)
Indian Journal of Sexually Transmitted Diseases and AIDS     Open Access   (Followers: 2)
International Archives of Medicine     Open Access   (Followers: 3)
International Journal of Dermatology     Hybrid Journal   (Followers: 15)
International Journal of Dermatology and Clinical Research     Open Access   (Followers: 1)
International Journal of Research in Dermatology     Open Access   (Followers: 1)
International Journal of STD & AIDS     Hybrid Journal   (Followers: 7)
International Journal of Women's Dermatology     Open Access   (Followers: 1)
International STD Research & Reviews     Open Access   (Followers: 1)
JAAD Case Reports     Open Access   (Followers: 1)
JAIDS : Journal of Acquired Immune Deficiency Syndromes     Hybrid Journal   (Followers: 4)
JAMA Dermatology     Full-text available via subscription   (Followers: 49)
JAMA Facial Plastic Surgery     Full-text available via subscription   (Followers: 12)
JMIR Dermatology     Open Access   (Followers: 1)
Journal of AIDS & Clinical Research     Open Access   (Followers: 3)
Journal of Clinical & Experimental Dermatology Research     Open Access   (Followers: 6)
Journal of Clinical and Investigative Dermatology     Open Access   (Followers: 2)
Journal of Cosmetic Dermatology     Hybrid Journal   (Followers: 10)
Journal of Cosmetics, Dermatological Sciences and Applications     Open Access   (Followers: 7)
Journal of Cutaneous Immunology and Allergy     Open Access  
Journal of Cutaneous Medicine and Surgery     Full-text available via subscription  
Journal of Dermatological Research     Open Access  
Journal of Dermatological Science     Hybrid Journal   (Followers: 2)
Journal of Dermatological Science Supplement     Full-text available via subscription   (Followers: 1)
Journal of Dermatological Treatment     Hybrid Journal   (Followers: 2)
Journal of Dermatology & Dermatologic Surgery     Open Access   (Followers: 1)
Journal of General-Procedural Dermatology & Venereology Indonesia     Open Access  
Journal of HIV/AIDS & Social Services     Hybrid Journal   (Followers: 9)
Journal of Investigative Dermatology     Hybrid Journal   (Followers: 28)
Journal of Investigative Dermatology Symposium Proceedings     Full-text available via subscription  
Journal of Sexual Medicine     Hybrid Journal   (Followers: 6)
Journal of Sexually Transmitted Diseases     Open Access   (Followers: 3)
Journal of Skin and Stem Cell     Open Access   (Followers: 3)
Journal of Skin Cancer     Open Access   (Followers: 3)
Journal of Surgical Dermatology     Open Access   (Followers: 1)
Journal of the American Academy of Dermatology     Full-text available via subscription   (Followers: 37)
Journal of the Dermatology Nurses' Association     Hybrid Journal   (Followers: 3)
Journal of the Egyptian Women’s Dermatologic Society     Partially Free  
Journal of the European Academy of Dermatology and Venereology     Hybrid Journal   (Followers: 15)
Journal of the International AIDS Society     Open Access   (Followers: 10)
Journal of the Saudi Society of Dermatology & Dermatologic Surgery     Open Access   (Followers: 1)
Karger Kompass Dermatologie     Full-text available via subscription  
Karger Kompass Pneumologie     Full-text available via subscription   (Followers: 1)
Langenbeck's Archives of Surgery     Hybrid Journal   (Followers: 4)
Medical and Surgical Dermatology     Hybrid Journal   (Followers: 1)
Medical Mycology     Open Access   (Followers: 4)
Nepal Journal of Dermatology, Venereology & Leprology     Open Access   (Followers: 1)
Neurobehavioral HIV Medicine     Open Access   (Followers: 2)
OA Dermatology     Open Access   (Followers: 1)
Open AIDS Journal     Open Access  
Open Dermatology Journal     Open Access  
Perspectives On Sexual and Reproductive Health     Hybrid Journal   (Followers: 7)
Pigment International     Open Access   (Followers: 1)
Psoriasis : Targets and Therapy     Open Access   (Followers: 4)
Revista Internacional de Ciencias Podológicas     Open Access  
SAHARA : Journal of Social Aspects of HIV / AIDS Research Alliance     Open Access   (Followers: 5)
Scars, Burns & Healing     Open Access  
Serbian Journal of Dermatology and Venereology     Open Access   (Followers: 1)
Sex Education: Sexuality, Society and Learning     Hybrid Journal   (Followers: 5)
Sexual & Reproductive Healthcare     Hybrid Journal   (Followers: 2)
Sexual Health     Hybrid Journal   (Followers: 4)
Sexually Transmitted Diseases     Hybrid Journal   (Followers: 6)
Sexually Transmitted Infections     Hybrid Journal   (Followers: 6)
Skin Appendage Disorders     Full-text available via subscription   (Followers: 1)
Skin Pharmacology and Physiology     Full-text available via subscription   (Followers: 7)
Skin Research and Technology     Hybrid Journal   (Followers: 7)
Southern African Journal of HIV Medicine     Open Access   (Followers: 3)
Sri Lanka Journal of Sexual Health and HIV Medicine     Open Access  
Studies in Gender and Sexuality     Hybrid Journal   (Followers: 21)
Surgical & Cosmetic Dermatology     Open Access   (Followers: 3)
The Journal of Dermatology     Hybrid Journal   (Followers: 5)
The Rose Sheet     Full-text available via subscription   (Followers: 2)
Vestnik dermatologii i venerologii     Open Access  
Veterinary Dermatology     Hybrid Journal   (Followers: 8)

           

Similar Journals
Journal Cover
Sexually Transmitted Infections
Journal Prestige (SJR): 1.626
Citation Impact (citeScore): 2
Number of Followers: 6  
 
  Hybrid Journal Hybrid journal (It can contain Open Access articles)
ISSN (Print) 1368-4973 - ISSN (Online) 1472-3263
Published by BMJ Publishing Group Homepage  [68 journals]
  • Highlights from this issue
    • Authors: Cassell; J. A.
      Pages: 237 - 237
      Abstract: Over the past month, I have been reading an enthralling book about the diagnosis and care of leprosy, long before germ theory and the formalisation of modern approaches to diagnosis.1 Carole Rawcliffe explores both familiar 19th century segregation approaches to infectious diseases, and the radically unfamiliar approaches of the mediaeval period and their evolution. The strangeness of leprosy, and its complex challenges to theories of disease from the humoral, through miasmatic to modern germ theory, should give us pause for thought as we consider candidates for status of emerging STIs which potentially need control and containment. This month we publish a meta-analysis of Mycoplasma genitalium prevalence in which the authors conclude that ‘low estimated prevalence of M. genitalium in the general population, pregnant women and asymptomatic attenders at clinics does not support expansion of testing to these groups’.2 An accompanying editorial by Tucker and colleagues
      Keywords: Sexual health
      PubDate: 2018-05-18T06:34:55-07:00
      DOI: 10.1136/sextrans-2018-053676
      Issue No: Vol. 94, No. 4 (2018)
       
  • BASHH/BHIVA mentoring scheme
    • Authors: Rubinstein, L; Fox, E.
      Pages: 239 - 239
      Abstract: Although there is no universally accepted definition of mentoring, the BASHH/British HIV Association (BHIVA) mentoring committee considers it to be a "personal helping relationship between a mentor and mentee/protégé that includes professional development and growth and varying degrees of support".1 Mentoring is particularly helpful at times of change, such as when a specialist trainee becomes a consultant, taking on new roles and responsibilities. The relationship between mentor and mentee is crucial; it must be open, honest and transparent and most importantly driven by the needs of the mentee. Mentoring is a confidential process with clear ethical boundaries, completely separate from line management, appraisal or performance assessment. Typically, the mentor helps the mentee formulate specific and realistic goals, and together they explore different ways these goals could be achieved, considering which option is most suitable for the mentee at that particular time. The mentor helps, guides and supports...
      Keywords: Sexual health
      PubDate: 2018-05-18T06:34:55-07:00
      DOI: 10.1136/sextrans-2018-053608
      Issue No: Vol. 94, No. 4 (2018)
       
  • Mycoplasma genitalium: an important sexually transmitted infection comes
           into focus
    • Authors: Tucker, J. D; Ong, J. J.
      Pages: 240 - 241
      Abstract: Invited commentary The bacterium Mycoplasma genitalium is frequently asymptomatic but can cause urethritis in men, and cervicitis, endometritis, pelvic inflammatory disease and infertility in women.1 2 Our understanding of this infection has rapidly expanded since it was first described at a British genitourinary medicine clinic nearly three decades ago.3 Biological and diagnostic issues have likely contributed to the blurriness surrounding this STI—it lacks a cell wall (and so is not visualised with routine Gram stain) and the fastidious organism requires 1–2 months to culture. In addition, the limited number of commercially available diagnostic tests has restricted testing and extensive epidemiological investigation. Currently, no routine serological diagnostics exist for M. genitalium and there are no US Food and Drug Administration-approved diagnostics. This daunting biology and diagnostic situation begs the question: why does detecting this pathogen matter when most empirical therapy covers the bacteria' Two...
      PubDate: 2018-05-18T06:34:55-07:00
      DOI: 10.1136/sextrans-2017-053517
      Issue No: Vol. 94, No. 4 (2018)
       
  • Using the eSexual Health Clinic to access chlamydia treatment and care via
           the internet: a qualitative interview study
    • Authors: Aicken, C. R. H; Sutcliffe, L. J, Gibbs, J, Tickle, L. J, Hone, K, Harding-Esch, E. M, Mercer, C. H, Sonnenberg, P, Sadiq, S. T, Estcourt, C. S, Shahmanesh, M.
      Pages: 241 - 247
      Abstract: ObjectiveWe developed the eSexual Health Clinic (eSHC), an innovative, complex clinical and public health intervention, embedded within a specialist sexual health service. Patients with genital chlamydia access their results online and are offered medical management via an automated online clinical consultation, leading to antibiotic collection from community pharmacy. A telephone helpline, staffed by Sexual Health Advisers, is available to support patients and direct them to conventional services if appropriate. We sought to understand how patients used this ehealth intervention.MethodsWithin exploratory studies of the eSHC (2014–2015), we conducted in-depth interviews with a purposive sample of 36 patients diagnosed with chlamydia, who had chosen to use the eSHC (age 18–35, 20 female, 16 male). Thematic analysis was conducted.ResultsParticipants described choosing to use this ehealth intervention to obtain treatment rapidly, conveniently and privately, within busy lifestyles that hindered clinic access. They described completing the online consultation promptly, discreetly and with ease. The information provided online was considered comprehensive, reassuring and helpful, but some overlooked it in their haste to obtain treatment. Participants generally described being able to collect treatment from pharmacies discreetly and promptly, but for some, poor awareness of the eSHC by pharmacy staff undermined their ability to do this. Those unsuitable for remote management, who were directed to clinic, described frustration and concern about health implications and clinic attendance. However, the helpline was a highly valued source of information, assistance and support.ConclusionThe eSHC is a promising adjunct to traditional care. Its users have high expectations for convenience, speed and privacy, which may be compromised when transitioning from online to face-to-face elements of the eSHC. Managing expectations and improving implementation of the pharmacy process, could improve their experiences. Positive views on the helpline provide further support for embedding this ehealth intervention within a specialist clinical service.
      Keywords: Open access
      PubDate: 2018-05-18T06:34:55-07:00
      DOI: 10.1136/sextrans-2017-053227
      Issue No: Vol. 94, No. 4 (2018)
       
  • How can we increase offer rates of human papillomavirus (HPV) vaccination
           among men who have sex with men (MSM) in routine sexual health
           clinics'
    • Authors: Parr, A; Pinto-Sander, N, Richardson, D.
      Pages: 247 - 247
      Abstract: In 2015, the Joint Committee on Vaccination and Immunisation recommended ‘A HPV-MSM immunisation programme should be introduced for MSM up to and including the age of 45 years who attend GUM and HIV clinics, subject to procurement of the vaccine and delivery of the programme at a cost-effective price’. Public Health England invited some genitourinary medicine (GUM) clinics to take part in a pilot study to evaluate the acceptability and feasibility of human papillomavirus (HPV) vaccination (Gardasil) in individuals attending routine GUM appointments. Uptake of HPV vaccination is dependent on healthcare workers (HCWs) offering the vaccine.1 To increase the offer rate, we wanted to understand local barriers to staff offering and delivering HPV vaccination. We sent an anonymous electronic survey to all staff delivering HPV vaccination in June 2017, 7 months after the pilot started. There were 41/104 (39%) responses from sexual health workers. Out of 40 respondents, 38 (95%) said that it was easy/very...
      PubDate: 2018-05-18T06:34:55-07:00
      DOI: 10.1136/sextrans-2017-053505
      Issue No: Vol. 94, No. 4 (2018)
       
  • Social determinants of community-level human papillomavirus vaccination
           coverage in aschool-based vaccination programme
    • Authors: Jean, S; Elshafei, M, Buttenheim, A.
      Pages: 248 - 253
      Abstract: ObjectiveTo assess social patterns in human papillomavirus (HPV) vaccine coverage in a school-based, government-funded vaccination programme located within a single-payer universal healthcare system.DesignWe conducted a cross-sectional analysis of HPV vaccine uptake data for the 2013–2014 school year for 131 local authorities in England, and then evaluated the association between vaccine uptake and socioeconomic status at the aggregate level.Data sourcesHPV vaccination coverage data from Public Health England’s vaccine uptake guidance and the UK’s March 2011 Census.Main outcome measuresWe measured three-dose local authority-level vaccine series initiation to completion.ResultsWe found that in local authorities where there are more high-income families, the vaccination rate is lower than in local authorities with more low-income families. Local authorities with a higher percentage of whites, compared with non-whites, had higher HPV vaccination rates. Additionally, local authorities with more non-migrants had higher rates of vaccination. Local authorities with more education deprivation had higher rates of vaccination. Local authorities’ higher proportions of high-status occupations had worse vaccination coverage. In bivariate analyses across all the socioeconomic indicators, a 1 SD change in the indicators was associated with about a 2.25 percentage point decrease (for income, education and occupation) or increase (for race and migrant composition) in HPV dose coverage in the local authority. In multivariable analyses, only race remained as a significant predictor of HPV coverage at the local authority level.ConclusionsAcross all three doses, there are notable variations by socioeconomic status, with steep reverse gradients in three socioeconomic indicators. More quantitative and qualitative research needs to be conducted to determine the effects of the 2014 transition from a three-dose regimen to two-dose regimen on vaccination coverage, especially in groups that experience lower rates of vaccination.
      PubDate: 2018-05-18T06:34:55-07:00
      DOI: 10.1136/sextrans-2017-053357
      Issue No: Vol. 94, No. 4 (2018)
       
  • Access to sexual health education and healthcare for adolescent women in
           rural Vermont: a qualitative study
    • Authors: Florsheim, O. K; Alarcon, J, Montanaro, E. A, Fiellin, L. E.
      Pages: 253 - 253
      Abstract: In the USA, one in four sexually active adolescents has an STI,1 and yet sexual health education and screening in this population is inadequate.2 Factors impacting adolescent women’s access to sexual healthcare include a misunderstanding of the symptoms, stigma and fear of embarrassment, issues around cost, and conflicting clinic and school schedule.2 The purpose of our study was to identify the perceived barriers to sexual health education and care that particularly affect adolescent women who live in rural communities. Twelve women, aged 14–20 years, were recruited from two public high schools in Bennington, Vermont. Participants completed a 15–20 min semistructured qualitative interview and survey between March and April 2015. Interviews included questions about experiences with school-based sexual health education, physicians and community resources related to HIV/STI testing. Three themes emerged from the interview analysis: (1) participants’ perceived barriers to adequate sexual education and...
      PubDate: 2018-05-18T06:34:55-07:00
      DOI: 10.1136/sextrans-2017-053471
      Issue No: Vol. 94, No. 4 (2018)
       
  • Prevalence of Mycoplasma genitalium in different population groups:
           systematic review andmeta-analysis
    • Authors: Baumann, L; Cina, M, Egli-Gany, D, Goutaki, M, Halbeisen, F. S, Lohrer, G.-R, Ali, H, Scott, P, Low, N.
      Pages: 255 - 262
      Abstract: Background Mycoplasma genitalium is a common cause of non-gonococcal non-chlamydial urethritis and cervicitis. Testing of asymptomatic populations has been proposed, but prevalence in asymptomatic populations is not well established. We aimed to estimate the prevalence of M. genitalium in the general population, pregnant women, men who have sex with men (MSM), commercial sex workers (CSWs) and clinic-based samples,MethodsWe searched Embase, Medline, IndMED, African Index Medicus and LILACS from 1 January 1991 to 12 July 2016 without language restrictions. We included studies with 500 participants or more. Two reviewers independently screened and selected studies and extracted data. We examined forest plots and conducted random-effects meta-analysis to estimate prevalence, if appropriate. Between-study heterogeneity was examined using the I2 statistic and meta-regression.ResultsOf 3316 screened records, 63 were included. In randomly selected samples from the general population, the summary prevalence was 1.3% (95% CI 1.0% to 1.8%, I2 41.5%, three studies, 9091 people) in countries with higher levels of development and 3.9% (95% CI 2.2 to 6.7, I2 89.2%, three studies, 3809 people) in countries with lower levels. Prevalence was similar in women and men (P=0.47). In clinic based samples, prevalence estimates were higher, except in asymptomatic patients (0.8%, 95% CI 0.4 to 1.4, I2 0.0%, three studies, 2889 people). Summary prevalence estimates were, in the following groups: pregnant women 0.9% (95% CI 0.6% to 1.4%, I2 0%, four studies, 3472 people), MSM in the community 3.2% (95% CI 2.1 to 5.1, I2 78.3%, five studies, 3012 people) and female CSWs in the community 15.9% (95% CI 13.5 to 18.9, I2 79.9%, four studies, 4006 people).DiscussionThis systematic review can inform testing guidelines for M. genitalium. The low estimated prevalence of M. genitalium in the general population, pregnant women and asymptomatic attenders at clinics does not support expansion of testing to these groups.Registration numbersPROSPERO: CRD42015020420
      Keywords: Open access, Editor's choice
      PubDate: 2018-05-18T06:34:55-07:00
      DOI: 10.1136/sextrans-2017-053384
      Issue No: Vol. 94, No. 4 (2018)
       
  • High prevalence of high-risk HPV genotypes other than 16 and 18 in
           cervical cancers of Curacao: implications for choice of prophylactic HPV
           vaccine
    • Authors: Hooi, D. J; Lissenberg-Witte, B. I, de Koning, M. N. C, Pinedo, H. M, Kenter, G. G, Meijer, C. J, Quint, W. G.
      Pages: 263 - 267
      Abstract: BackgroundCuracao is a Dutch-Caribbean Island located in a high-risk area for cervical cancer.Prior to introduction of a prophylactic human papillomavirus (HPV) vaccine, knowledge of the prevalence of high-risk HPV vaccine genotypes (HPV16, 18, 31, 33, 45, 52 and 58) in cervical (pre)cancer is required.ObjectiveTo investigate the prevalence of HPV genotypes in invasive cervical cancers (ICC) and cervical intraepithelial neoplasia (CIN) grade 1, 2 and 3 in Curacao.MethodsParaffin-embedded blocks of 104 cervical cancers (89 squamous, 15 adenocarcinoma), 41 CIN3, 39 CIN2 and 40 CIN1 lesions were analysed for the presence of HPV. Sections were stained by H&E for histopathological evaluation, and DNA was extracted using proteinase K. HPV genotypes were detected using Short PCR Fragment (SPF10) PCR DNA enzyme immunoassay and a Line Probe Assay (LiPA25) .ResultsHPV was found in 92 (88.5%) ICC; 87 (94.6%) had a single HPV infection and 86 (93.5%) were high-risk human papillomavirus (hrHPV)-type positive.The three most common HPV types in ICC were 16 (38.5%), 18 (13.5%) and 45 (6.7%), covering 58.7%.HrHPV vaccine genotypes 16, 18, 31, 35, 45, 52 and 58 were responsible for 73.1% of ICC. For precancerous lesions, the HPV attribution was 85.4% for CIN3, 66.7% for CIN2% and 42.5% for CIN1.ConclusionsOur study, the largest in the Caribbean region in (pre)cancer, shows that the prevalence of HPV-type 16 and 18 in cervical cancer is lower compared with the world population but no differences in prevalence of these two HPV types are seen in precancerous lesions.When considering HPV vaccination in Curacao, the relatively high contribution of non-HPV 16/18 genotypes in ICC should be taken into account.
      Keywords: Open access
      PubDate: 2018-05-18T06:34:55-07:00
      DOI: 10.1136/sextrans-2017-053109
      Issue No: Vol. 94, No. 4 (2018)
       
  • Sexual health clinic attendance and non-attendance in Britain: findings
           from the third National Survey of Sexual Attitudes and Lifestyles
           (Natsal-3)
    • Authors: Tanton, C; Geary, R. S, Clifton, S, Field, N, Heap, K. L, Mapp, F, Hughes, G, Johnson, A. M, Cassell, J. A, Sonnenberg, P, Mercer, C. H.
      Pages: 268 - 276
      Abstract: ObjectivesIn Britain, sexual health clinics (SHCs) are the most common location for STI diagnosis but many people with STI risk behaviours do not attend. We estimate prevalence of SHC attendance and how this varies by sociodemographic and behavioural factors (including unsafe sex) and describe hypothetical service preferences for those reporting unsafe sex.MethodsComplex survey analyses of data from Britain’s third National Survey of Sexual Attitudes and Lifestyles, a probability survey of 15 162 people aged 16–74 years, undertaken 2010–2012.ResultsOverall, recent attendance (past year) was highest among those aged 16–24 years (16.6% men, 22.4% women), decreasing with age (75% of these had not attended a SHC (past year). However, of non-attenders aged 16–44 years, 18.7% of men and 39.0% of women reported chlamydia testing (past year) with testing highest in women aged
      Keywords: Open access
      PubDate: 2018-05-18T06:34:55-07:00
      DOI: 10.1136/sextrans-2017-053193
      Issue No: Vol. 94, No. 4 (2018)
       
  • Prevalence and sociodemographic correlates of cervicovaginal human
           papillomavirus (HPV) carriage in a cross-sectional, multiethnic,
           community-based female Asian population
    • Authors: Khoo, S. P; Bhoo-Pathy, N, Yap, S. H, Anwar Shafii, M. K, Hairizan Nasir, N, Belinson, J, Subramaniam, S, Goh, P. P, Zeng, M, Tan, H. D, Gravitt, P, Woo, Y. L.
      Pages: 277 - 283
      Abstract: ObjectivesCervical cancer is a largely preventable disease, and the strategic implementation of a cervical cancer prevention programme is partly dependent on the impact of human papillomavirus (HPV) infection interpreted within the context of the country’s sociodemographic attributes. The objective of this study is to determine the prevalence of cervicovaginal HPV infection among a healthy, community-based, multiethnic Malaysian population. The HPV prevalence was subsequently correlated to the individual’s sociodemographics and sexual/reproductive history. Of significance, the observed prevalence captured was in a birth cohort not included in the national school-based HPV vaccination programme.MethodsThis was a cross-sectional study where 1293 healthy women aged between 18 and 60 years were recruited via convenience sampling from five community-based clinics in Selangor, Malaysia. Cervicovaginal self-samples were obtained and DNA was extracted for HPV detection and genotyping. A comprehensive questionnaire was administered to determine the sociodemographics and behavioural patterns of participants.ResultsThe median age at enrolment was 37 years old (IQR: 30–47). In total, 86/1190 (7.2%) of the samples collected were positive for HPV infection, with the highest HPV prevalence (11.9%) detected in the subgroup of 18–24 years old. The top three most prevalent HPV genotypes were HPV 16, 52 and 58. The independent risk factors associated with higher rates of HPV infection included Indian ethnicity, widowed status and women with partners who are away from home for long periods and/or has another sexual partner.ConclusionsThe overall prevalence of HPV infection in this Malaysian multiethnic population was 7.2%, with 6.5% being high-risk genotypes. The top three most common high-risk HPV types were HPV 16, 52 and 58. This information is important for the planning of primary (HPV vaccination) and secondary (screening) cervical cancer prevention programmes in Malaysia.
      Keywords: Screening (epidemiology)
      PubDate: 2018-05-18T06:34:55-07:00
      DOI: 10.1136/sextrans-2017-053320
      Issue No: Vol. 94, No. 4 (2018)
       
  • High HIV incidence among young black men who have sex with men:
           constructing a retrospective cohort from a community health programme
    • Authors: Friedman, M. R; Feliz, N. B, Netto, J, Adams, B. J, Matthews, D. D, Stall, R. D, Ho, K. S, Krier, S. E, Silvestre, A. J.
      Pages: 284 - 286
      Abstract: ObjectivesWe sought to calculate HIV incidence in a retrospective cohort of young (13–29 years old) black men who have sex with men (YBMSM) accessing repeated HIV-antibody testing in a mid-size city in the USA.MethodsWe aggregated site-specific HIV-antibody testing results from the project's inception among YBMSM who received an initial negative result and accessed at least one additional HIV-antibody test. From these data, we assessed number of seroconversions and person-years and calculated HIV incidence using a mid-P exact test to estimate 95% CIs.ResultsFive seroconversions were documented over 42.3 person-years (the mean age at first onsite test: 19.7 years), resulting in an HIV incidence rate of 11.8% (95% CI 4.3% to 26.2%). The mean age at seroconversion was 20.4 (±3.0) years.ConclusionsEven in mid-size cities with low HIV prevalence rates in the general population, HIV incidence among YBMSM may be high. Community-based HIV-antibody testing organisations serving YBMSM should be encouraged and trained to track repeated HIV testing and calculate HIV incidence rates. Increased resources should be deployed to develop and encourage regular HIV testing in community health sites serving YBMSM.
      PubDate: 2018-05-18T06:34:55-07:00
      DOI: 10.1136/sextrans-2016-052722
      Issue No: Vol. 94, No. 4 (2018)
       
  • Sampling technique and detection rates of oropharyngeal and anorectal
           gonorrhoea using nucleic acid amplification tests in men who have sex with
           men
    • Authors: Yang, T. Z. T; Chen, M. Y, Read, T. R. H, Needleman, R, Bradshaw, C. S, Fortune, R, Fairley, C. K, Chow, E. P. F.
      Pages: 287 - 292
      Abstract: ObjectivesThe objective of this study was to examine the associations between clinicians’ self-reported sampling technique and the detection rate of gonorrhoea at the oropharynx and anorectum using a highly sensitive nucleic acid amplification test (NAAT).MethodsWe analysed oropharyngeal and anorectal gonorrhoea swab results among men who have sex with men attending the Melbourne Sexual Health Centre (MSHC) between March 2015 and December 2016. Swabs were tested by NAAT using the Aptima Combo 2 transcription-mediated amplification assay due to its high sensitivity. Clinicians at MSHC were invited to complete a questionnaire on sampling techniques in November 2016. Univariable generalised estimating equations (GEE) logistic regressions were performed to determine the association between gonorrhoea detection rates and clinicians’ sampling technique. Patients’ epidemiological risk factors were included in the multivariable GEE logistic model.ResultsA total of 2605 oropharyngeal gonorrhoea and 2392 anorectal gonorrhoea swab results were analysed. There was no significant difference in the detection rates of gonorrhoea between the 23 clinicians at the oropharynx (range 3.6%–16.9%, median 8.2%, P=0.302) or and anorectum (range 2.4%–17.3%, median 10.5%, P=0.177). Variations in clinicians’ self-reported sampling technique were not associated with oropharyngeal or anorectal gonorrhoea detection rates after adjusting for patients’ epidemiological risk factors.ConclusionsThis study shows that differences in clinicians’ self-reported sampling technique did not result in measurable differences in the detection rate for oropharyngeal or anorectal gonorrhoea when using NAAT.
      Keywords: Screening (epidemiology)
      PubDate: 2018-05-18T06:34:55-07:00
      DOI: 10.1136/sextrans-2017-053339
      Issue No: Vol. 94, No. 4 (2018)
       
  • Detection of Neisseria gonorrhoeae and Chlamydia trachomatis from pooled
           rectal, pharyngeal and urine specimens in men who have sex with men
    • Authors: Speers, D. J; Chua, I.-L. J, Manuel, J, Marshall, L.
      Pages: 293 - 297
      Abstract: ObjectivesScreening of men who have sex with men (MSM) for Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) requires sampling from anorectal and pharyngeal sites in addition to urogenital sampling. Due to the cost of testing multiple anatomical sites individually testing of pooled specimens has potential merit. The Cepheid GeneXpert CT/NG assay (GeneXpert), which also has potential for point-of-care nucleic acid testing in the sexual health clinic, has not been assessed for pooled specimen testing.MethodsWe prospectively compared GeneXpert testing of pooled pharyngeal and rectal swabs with urine samples to standard of care testing of individual specimens from 107 participants using the Roche cobas 4800 CT/NG assay (cobas) for CT and NG in high-risk MSM attending an inner city sexual health clinic.ResultsWe found testing of pooled pharyngeal, rectal and urine samples by the GeneXpert to have 100% agreement for NG and 94% overall agreement for CT when compared with individual specimen testing by cobas. For CT testing, 14 cases were detected for both tests, 4for cobas only, 2 for GeneXpert only and 89 participants were negative for both tests.ConclusionsPooled specimen CT and NG testing by the GeneXpert was accurate when compared with single specimen testing and has potential for screening MSM for CT and NG. The role of pooled specimen testing with the GeneXpert as a point-of-care nucleic acid test in MSM requires further investigation.
      Keywords: Sexual health
      PubDate: 2018-05-18T06:34:55-07:00
      DOI: 10.1136/sextrans-2017-053303
      Issue No: Vol. 94, No. 4 (2018)
       
  • Acute hepatitis C in HIV-negative men who have sex with men in the
           Netherlands and Belgium: a call for action
    • Authors: Boerekamps, A; Wouters, K, Ammerlaan, H. S. M, Götz, H. M, Laga, M, Rijnders, B. J. A.
      Pages: 297 - 297
      Abstract: The evidence that HIV treatment as prevention (TaSP) and HIV pre-exposure prophylaxis (PrEP) reduce the risk of HIV transmission is overwhelming. The logical consequence of both interventions is that sexual mixing between HIV-positive and negative men who have sex with men (MSM) will increase. Hepatitis C (HCV) can be sexually transmitted in MSM and until recently was thought to be limited to HIV-infected MSM. However, from January 2016 to July 2017, through the Dutch Acute HCV in HIV Study (a Dutch-Belgian prospective multicentre study on the treatment of acute HCV, NCT02600325) and the Be-PrEP-ared study (a PrEP project in Antwerp, Eudra CT2015-000054-37), 10 cases of acute HCV were reported in HIV-negative MSM. In these cases, HCV was diagnosed at an STI clinic (n=2) by the general practitioner (n=2), by the infectiologist (n=1) or at a PrEP clinic (n=5). Of the patients diagnosed at the PrEP clinic, one was diagnosed before the start...
      PubDate: 2018-05-18T06:34:55-07:00
      DOI: 10.1136/sextrans-2018-053526
      Issue No: Vol. 94, No. 4 (2018)
       
  • Treatment of chlamydia and gonorrhoea, compliance with treatment
           guidelines and factors associatedwith non-compliant prescribing: findings
           form a cross-sectional study
    • Authors: Tisler-Sala, A; Ojavee, S.-E, Uusküla, A.
      Pages: 298 - 303
      Abstract: ObjectivesProper antibiotic treatment of STI reduces transmission, antimicrobial resistance and serious disease complications. In this study, we assessed compliance with STI treatment guidelines for genital gonorrhoea and chlamydia infections in Estonia.MethodsPrescription data from the Estonian Health Insurance Fund on 7556 treatment episodes of 6499 patients treated for gonorrhoea or chlamydia during 2012–2014 were analysed to assess compliance with the guidelines and factors associated with it.ResultsBetween 1 January 2012 and 31 December 2014, a total of 6074 patients were treated for chlamydia and 425 for gonorrhoea in Estonia. Among all prescriptions, 48.6% were non-compliant with gonorrhoea treatment guidelines and 3.8% for chlamydia. Non-compliant antibiotic treatment for gonorrhoea was associated with patient gender (female (adjusted OR (AOR)) 3.0, 95% CI 1.6 to 5.9), region (east AOR 3.3, 95% CI 1.3 to 8.2; west AOR 6.5, 95% CI 2.2 to 19.7) and prescribing physician specialty (general healthcare doctors: AOR 5.6, 95% CI 2.3 to 13.8; gynaecologists: AOR 5.9, 95% CI 2.8 to 12.4). Non-compliant antibiotic treatment for chlamydia was associated with younger patient age (15–24 AOR 0.5, 95% CI 0.4 to 0.7), region (north AOR 1.9, 95% CI 1.4 to 2.6; west AOR 2.3, 95% CI 1.5 to 3.4) and multiple treatment episodes (AOR 2.7, 95% CI 2.1 to 3.9). Approximately 14% of prescriptions were multiple treatments for the same patient for the same infection over the 3-year period (6.1% for gonorrhoea and 14.5% for chlamydia).ConclusionThere are significant differences in terms of compliance with treatment guidelines for gonorrhoea and chlamydia, and several factors associated with non-compliance that can potentially be targeted with interventions. Future research should explore reasons clinicians do not follow guidelines and examine ways to improve practice among doctors and patients and assess factors associated with multiple treatments, particularly multiple treatments for the same STI.
      PubDate: 2018-05-18T06:34:55-07:00
      DOI: 10.1136/sextrans-2017-053247
      Issue No: Vol. 94, No. 4 (2018)
       
  • A cross-sectional study examining associations between substance use
           frequency, problematic use and STIs among youth living with HIV
    • Authors: Gamarel, K. E; Nichols, S, Kahler, C. W, Westfall, A. O, Lally, M. A, Wilson, C. M, the Adolescent Medicine Trials Network for HIV/AIDS Intervention
      Pages: 304 - 308
      Abstract: ObjectivesThis study sought to examine the prevalence of STIs and whether substance use frequency and/or problematic use—specifically alcohol, marijuana and other drugs—was associated with having an STI diagnosis among youth living with HIV (YLWH)MethodsA sample of 823 YLWH were recruited at 14 adolescent HIV clinics through the Adolescent Medicine Trials Network for HIV Interventions. Study staff abstracted STI data from medical records for up to 26 weeks prior to participants’ completing a cross-sectional survey including the ASSIST (Alcohol, Smoking and Substance Involvement Screening Test), which measures substance use frequency and consequences.ResultsAlmost one-third of youth had been diagnosed with an STI (30.5%) at the time of their baseline assessment. In multivariable analyses, those who engaged in weekly or greater marijuana use (adjusted OR (AOR)=10.66, 95% CI: 4.39 to 25.87, P
      PubDate: 2018-05-18T06:34:55-07:00
      DOI: 10.1136/sextrans-2017-053334
      Issue No: Vol. 94, No. 4 (2018)
       
  • Measuring and understanding the attitudes of Australian gay and bisexual
           men towards biomedical HIV prevention using cross-sectional data and
           factor analyses
    • Authors: Wilkinson, A. L; Draper, B. L, Pedrana, A. E, Asselin, J, Holt, M, Hellard, M. E, Stoove, M.
      Pages: 309 - 314
      Abstract: IntroductionContemporary responses to HIV embrace biomedical prevention, particularly treatment as prevention (TasP) and pre-exposure prophylaxis (PrEP). However, large-scale implementation of biomedical prevention should be ideally preceded by assessments of their community acceptability. We aimed to understand contemporary attitudes of gay and bisexual men (GBM) in Australia towards biomedical-based HIV prevention and propose a framework for their measurement and ongoing monitoring.MethodsA cross-sectional, online survey of GBM ≥18 years has been conducted annually in Victoria, Australia, since 2008. In 2016, 35 attitudinal items on biomedical HIV prevention were added. Items were scored on five-point Likert scales. We used principal factor analysis to identify key constructs related to GBM’s attitudes to biomedical HIV prevention and use these to characterise levels of support for TasP and PrEP.ResultsA total of 462 HIV-negative or HIV-status-unknown men, not using PrEP, provided valid responses for all 35 attitudinal items. We extracted four distinct and interpretable factors we named: ‘Confidence in PrEP’, ‘Judicious approach to PrEP’, ‘Treatment as prevention optimism’ and ‘Support for early treatment’. High levels of agreement were seen across PrEP-related items; 77.9% of men agreed that PrEP prevented HIV acquisition and 83.6% of men agreed that users were protecting themselves. However, the agreement levels for HIV TasP items were considerably lower, with
      PubDate: 2018-05-18T06:34:55-07:00
      DOI: 10.1136/sextrans-2017-053375
      Issue No: Vol. 94, No. 4 (2018)
       
 
JournalTOCs
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Email: journaltocs@hw.ac.uk
Tel: +00 44 (0)131 4513762
 


Your IP address: 3.235.74.184
 
Home (Search)
API
About JournalTOCs
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-